Core Laboratories N.V.

NYSE: CLB · Real-Time Price · USD
10.61
-0.13 (-1.21%)
At close: Aug 14, 2025, 3:59 PM
10.60
-0.09%
Pre-market: Aug 15, 2025, 08:45 AM EDT

Core Laboratories Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
130.16M 123.58M 129.24M 134.4M 130.58M 129.64M 128.21M 125.34M 127.88M 128.36M 127.57M 125.97M 120.9M 115.3M 125.14M 117.98M 118.75M 108.38M
Cost of Revenue
107.37M 103.19M 109.86M 110.48M 106.7M 108.43M 105.39M 100.55M 104.23M 105.57M 103.89M 103.1M 102.32M 101.51M 101.39M 97.41M 98.59M 89.02M
Gross Profit
22.79M 20.4M 19.37M 23.92M 23.88M 21.21M 22.82M 24.8M 23.65M 22.78M 23.68M 22.86M 18.58M 13.79M 23.75M 20.57M 20.15M 19.36M
Operating Income
15.29M 4.42M 14.17M 19.8M 16.01M 8.57M 14.58M 14.67M 18.17M 6.48M 15.62M 14.64M 11.65M -391K 14.2M 6.64M 12.8M 11.62M
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
12.58M 1.81M 11.54M 16.7M 12.8M 5.15M 10.96M 11.53M 15.67M 3.05M 12.54M 11.51M 8.95M -3.04M 11.61M 3.97M 10.27M 10.26M
Net Income
10.64M -154K 7.4M 11.74M 9.03M 3.22M 2.2M 9.26M 22.85M 2.37M 6.75M 7.52M 7.07M -1.84M 2.69M 874K 8.06M 8.11M
Selling & General & Admin
10.46M 13.65M 9.08M 8.33M 10.26M 11.79M 8.29M 9.12M 5.81M 16.33M 8.72M 10M 6.85M 12.54M 10.93M 15.12M 9.67M 8.46M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
n/a 2.33M -3.88M -4.21M -2.39M 846K -54K 1.01M 330K -28K -660K -1.78M n/a n/a n/a n/a n/a n/a
Operating Expenses
10.46M 15.98M 5.2M 4.11M 7.87M 12.63M 8.24M 10.13M 5.48M 16.3M 8.06M 8.22M 6.85M 12.54M 10.93M 15.12M 9.67M 8.46M
Interest Expense
2.71M 2.6M 2.63M 3.11M 3.21M 3.42M 3.62M 3.15M 3.24M 3.43M 3.08M 3.14M 2.71M 2.64M 2.59M 2.67M 2.53M 1.36M
Selling & Marketing Expenses
n/a n/a n/a n/a -287K 290K -373K -336K 330K n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
117.83M 119.17M 115.06M 114.59M 114.57M 121.07M 114.06M 110.67M 109.71M 121.88M 111.95M 111.32M 109.16M 114.05M 112.31M 112.53M 108.26M 97.48M
Income Tax Expense
1.91M 1.75M 4.08M 4.69M 3.61M 1.66M 8.53M 2.31M -7.26M 610K 5.85M 3.86M 1.79M -1.2M 8.82M 2.96M 2.05M 2.05M
Shares Outstanding (Basic)
47.51M 46.77M 46.83M 46.92M 46.91M 46.86M 46.86M 46.69M 46.67M 46.63M 46.36M 46.34M 46.32M 46.3M 46.35M 46.29M 46.32M 45.18M
Shares Outstanding (Diluted)
47.51M 46.77M 47.77M 47.82M 47.74M 47.7M 47.56M 47.6M 47.5M 47.48M 46.83M 47.01M 47.14M 46.3M 46.93M 47.13M 47.1M 45.96M
EPS (Basic)
0.22 -0.00 0.16 0.25 0.19 0.07 0.05 0.20 0.49 0.05 0.15 0.16 0.15 -0.04 0.06 0.02 0.17 0.18
EPS (Diluted)
0.22 -0.00 0.16 0.25 0.19 0.07 0.05 0.19 0.48 0.05 0.14 0.16 0.15 -0.04 0.06 0.02 0.17 0.18
EBITDA
22.64M 8.1M 17.84M 23.48M 19.78M 12.41M 18.45M 18.6M 22.11M 10.53M 19.69M 18.82M 11.65M 4.17M 18.6M 11.14M 12.8M 16.49M
EBIT
15.29M 4.42M 14.17M 19.8M 16.01M 8.57M 14.58M 14.67M 18.33M 6.48M 15.62M 14.64M 13.59M -391K 14.2M 6.64M 15.45M 11.62M
Depreciation & Amortization
7.39M 3.72M 3.66M 3.68M 3.77M 3.84M 3.87M 3.93M 3.94M 4.04M 4.07M 4.17M 11.55M 4.56M 4.4M 4.5M 11.9M 4.87M